Your browser doesn't support javascript.
loading
Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study.
Yap, Timothy A; Nakagawa, Kazuhiko; Fujimoto, Nobukazu; Kuribayashi, Kozo; Guren, Tormod Kyrre; Calabrò, Luana; Shapira-Frommer, Ronnie; Gao, Bo; Kao, Steven; Matos, Ignacio; Planchard, David; Chatterjee, Arkendu; Jin, Fan; Norwood, Kevin; Kindler, Hedy L.
Afiliación
  • Yap TA; Drug Development Unit, Royal Marsden Hospital, London, UK. Electronic address: tyap@mdanderson.org.
  • Nakagawa K; Department of Medical Oncology, Kindai University Hospital, Osaka, Japan.
  • Fujimoto N; Department of Medical Oncology, Okayama Rosai Hospital, Okayama, Japan.
  • Kuribayashi K; Department of Respiratory Medicine and Hematology, Hyogo College of Medicine, Hyogo, Japan.
  • Guren TK; Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Calabrò L; Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy.
  • Shapira-Frommer R; Chaim Sheba Medical Center, Ramat Gan, Israel.
  • Gao B; Blacktown Hospital, Blacktown, NSW, Australia.
  • Kao S; Chris O'Brien Lifehouse, Camperdown, NSW, Australia.
  • Matos I; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Planchard D; Department of Medical Oncology, Thoracic Unit, Gustave Roussy, Villejuif, France.
  • Chatterjee A; Merck & Co, Inc, Kenilworth, NJ, USA.
  • Jin F; Merck & Co, Inc, Kenilworth, NJ, USA.
  • Norwood K; Merck & Co, Inc, Kenilworth, NJ, USA.
  • Kindler HL; University of Chicago, Chicago, IL, USA.
Lancet Respir Med ; 9(6): 613-621, 2021 06.
Article en En | MEDLINE | ID: mdl-33836153
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados / Antineoplásicos Inmunológicos / Mesotelioma Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Respir Med Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados / Antineoplásicos Inmunológicos / Mesotelioma Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Respir Med Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido